Oberweis Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Oberweis Asset Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-93,400	Closed	-$813K	–	244
2018 Q2	$813K	Buy	93,400 +13,400	+17%	+$121K	0.2%	119
2018 Q1	$812K	Buy	+80,000	New	+$672K	0.21%	105

Oberweis Asset Management's JNP Position: Q3 2018 in Review

Oberweis Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 93,400 shares — an estimated $813K sold.

Oberweis Asset Management first reported a position in JNP in Q1 2018 and held it in 2 quarters. The position peaked at $813K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Oberweis Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Oberweis Asset Management sold 93,400 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $813K.
Oberweis Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
Oberweis Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $813K in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Oberweis Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.